Cassava Sciences, Inc. (SAVA) Social Stream



Cassava Sciences, Inc. (SAVA): $21.72

0.08 (-0.37%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add SAVA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#141 of 360

in industry

CASSAVA SCIENCES INC (SAVA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CASSAVA SCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-11 2 $190 $108 $140.666 $26.41 432.62%
2022-03-01 3 $190 $72 $128.666 $26.41 387.19%
2022-04-07 3 $190 $8 $98.5 $26.41 272.96%
2022-04-08 4 $124 $8 $78.5 $26.41 197.24%
2022-06-02 4 $124 $8 $75 $26.41 183.98%
2022-07-28 2 $124 $8 $63.333 $26.41 139.81%
2022-08-04 3 $124 $8 $63.333 $26.41 139.81%
2022-11-08 3 $124 $8 $58.666 $26.41 122.14%
2022-11-09 3 $124 $12 $60 $26.41 127.19%
2022-11-16 3 $124 $12 $60 $26.41 127.19%
2022-11-29 3 $124 $11 $59.666 $26.41 125.92%
2023-03-06 2 $124 $28 $76 $26.41 187.77%
2023-11-08 1 $124 $124 $124 $26.41 369.52%

The Trend in the Analyst Price Target


SAVA's average price target has moved up $104.67 over the prior 34 months.

SAVA reports an average of 350.63% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-06 2 124 124 124 26.29 371.66%
2023-03-06 1 124 28 76 26.29 189.08%
2023-03-06 1 124 124 124 26.29 371.66%
2023-07-06 1 124 124 124 22.91 441.25%
2023-10-04 1 124 124 124 18.84 558.17%

SAVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


SAVA's average broker recommendation rating improved by 1.33 over the prior 15 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • SAVA has a lower variance in analysts' estimates than -1296.19% of all US stocks.
  • In terms of how CASSAVA SCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 105.54% of that group.
  • SAVA has a higher upside potential (average analyst target price relative to current price) than 1405.7% of stocks in the mid market cap category.
  • In terms of how CASSAVA SCIENCES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 1309.57% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CASSAVA SCIENCES INC are CYTK, DVAX, and TGTX.

What is the outlook for SAVA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!